186 related articles for article (PubMed ID: 27507672)
1. Homocysteine metabolism is associated with cerebrospinal fluid levels of soluble amyloid precursor protein and amyloid beta.
Oikonomidi A; Lewczuk P; Kornhuber J; Smulders Y; Linnebank M; Semmler A; Popp J
J Neurochem; 2016 Oct; 139(2):324-332. PubMed ID: 27507672
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease.
Popp J; Lewczuk P; Linnebank M; Cvetanovska G; Smulders Y; Kölsch H; Frommann I; Kornhuber J; Maier W; Jessen F
J Alzheimers Dis; 2009; 18(4):819-28. PubMed ID: 19661622
[TBL] [Abstract][Full Text] [Related]
3. Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's disease.
Arlt S; Schwedhelm E; Kölsch H; Jahn H; Linnebank M; Smulders Y; Jessen F; Böger RH; Popp J
J Alzheimers Dis; 2012; 31(4):751-8. PubMed ID: 22710910
[TBL] [Abstract][Full Text] [Related]
4. Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid.
Obeid R; Kasoha M; Knapp JP; Kostopoulos P; Becker G; Fassbender K; Herrmann W
Clin Chem; 2007 Jun; 53(6):1129-36. PubMed ID: 17384003
[TBL] [Abstract][Full Text] [Related]
5. Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluid.
Smith DE; Smulders YM; Blom HJ; Popp J; Jessen F; Semmler A; Farkas M; Linnebank M
Clin Chem Lab Med; 2012 Mar; 50(9):1641-7. PubMed ID: 22962226
[TBL] [Abstract][Full Text] [Related]
6. Soluble amyloid precursor protein α and β in CSF in Alzheimer's disease.
Brinkmalm G; Brinkmalm A; Bourgeois P; Persson R; Hansson O; Portelius E; Mercken M; Andreasson U; Parent S; Lipari F; Ohrfelt A; Bjerke M; Minthon L; Zetterberg H; Blennow K; Nutu M
Brain Res; 2013 Jun; 1513():117-26. PubMed ID: 23541617
[TBL] [Abstract][Full Text] [Related]
7. Heteromers of amyloid precursor protein in cerebrospinal fluid.
Cuchillo-Ibañez I; Lopez-Font I; Boix-Amorós A; Brinkmalm G; Blennow K; Molinuevo JL; Sáez-Valero J
Mol Neurodegener; 2015 Jan; 10():2. PubMed ID: 25573162
[TBL] [Abstract][Full Text] [Related]
8. Amyloid and tau cerebrospinal fluid biomarkers in HIV infection.
Gisslén M; Krut J; Andreasson U; Blennow K; Cinque P; Brew BJ; Spudich S; Hagberg L; Rosengren L; Price RW; Zetterberg H
BMC Neurol; 2009 Dec; 9():63. PubMed ID: 20028512
[TBL] [Abstract][Full Text] [Related]
9. One-carbon metabolism, cognitive impairment and CSF measures of Alzheimer pathology: homocysteine and beyond.
Dayon L; Guiraud SP; Corthésy J; Da Silva L; Migliavacca E; Tautvydaitė D; Oikonomidi A; Moullet B; Henry H; Métairon S; Marquis J; Descombes P; Collino S; Martin FJ; Montoliu I; Kussmann M; Wojcik J; Bowman GL; Popp J
Alzheimers Res Ther; 2017 Jun; 9(1):43. PubMed ID: 28623948
[TBL] [Abstract][Full Text] [Related]
10. Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease.
Bekris LM; Galloway NM; Millard S; Lockhart D; Li G; Galasko DR; Farlow MR; Clark CM; Quinn JF; Kaye JA; Schellenberg GD; Leverenz JB; Seubert P; Tsuang DW; Peskind ER; Yu CE
Neurobiol Aging; 2011 Mar; 32(3):556.e13-23. PubMed ID: 21196064
[TBL] [Abstract][Full Text] [Related]
11. S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease.
Linnebank M; Popp J; Smulders Y; Smith D; Semmler A; Farkas M; Kulic L; Cvetanovska G; Blom H; Stoffel-Wagner B; Kölsch H; Weller M; Jessen F
Neurodegener Dis; 2010; 7(6):373-8. PubMed ID: 20523031
[TBL] [Abstract][Full Text] [Related]
12. Biomarkers of folate and vitamin B12 are related in blood and cerebrospinal fluid.
Obeid R; Kostopoulos P; Knapp JP; Kasoha M; Becker G; Fassbender K; Herrmann W
Clin Chem; 2007 Feb; 53(2):326-33. PubMed ID: 17200133
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol metabolism is associated with soluble amyloid precursor protein production in Alzheimer's disease.
Popp J; Lewczuk P; Kölsch H; Meichsner S; Maier W; Kornhuber J; Jessen F; Lütjohann D
J Neurochem; 2012 Oct; 123(2):310-6. PubMed ID: 22845771
[TBL] [Abstract][Full Text] [Related]
14. Young to Middle-Aged Dogs with High Amyloid-β Levels in Cerebrospinal Fluid are Impaired on Learning in Standard Cognition tests.
Borghys H; Van Broeck B; Dhuyvetter D; Jacobs T; de Waepenaert K; Erkens T; Brooks M; Thevarkunnel S; Araujo JA
J Alzheimers Dis; 2017; 56(2):763-774. PubMed ID: 28035921
[TBL] [Abstract][Full Text] [Related]
15. Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature.
Alexopoulos P; Guo LH; Jiang M; Bujo H; Grimmer T; Förster S; Drzezga A; Kurz A; Perneczky R
J Alzheimers Dis; 2013; 36(2):401-8. PubMed ID: 23609762
[TBL] [Abstract][Full Text] [Related]
16. Methylation status and neurodegenerative markers in Parkinson disease.
Obeid R; Schadt A; Dillmann U; Kostopoulos P; Fassbender K; Herrmann W
Clin Chem; 2009 Oct; 55(10):1852-60. PubMed ID: 19679632
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
Augutis K; Axelsson M; Portelius E; Brinkmalm G; Andreasson U; Gustavsson MK; Malmeström C; Lycke J; Blennow K; Zetterberg H; Mattsson N
Mult Scler; 2013 Apr; 19(5):543-52. PubMed ID: 23069872
[TBL] [Abstract][Full Text] [Related]
18. Diurnal patterns of soluble amyloid precursor protein metabolites in the human central nervous system.
Dobrowolska JA; Kasten T; Huang Y; Benzinger TL; Sigurdson W; Ovod V; Morris JC; Bateman RJ
PLoS One; 2014; 9(3):e89998. PubMed ID: 24646516
[TBL] [Abstract][Full Text] [Related]
19. Marked increase of beta-amyloid(1-42) and amyloid precursor protein in ventricular cerebrospinal fluid after severe traumatic brain injury.
Olsson A; Csajbok L; Ost M; Höglund K; Nylén K; Rosengren L; Nellgård B; Blennow K
J Neurol; 2004 Jul; 251(7):870-6. PubMed ID: 15258792
[TBL] [Abstract][Full Text] [Related]
20. APP-derived peptides reflect neurodegeneration in frontotemporal dementia.
Illán-Gala I; Pegueroles J; Montal V; Alcolea D; Vilaplana E; Bejanin A; Borrego-Écija S; Sampedro F; Subirana A; Sánchez-Saudinós MB; Rojas-García R; Vanderstichele H; Blesa R; Clarimón J; Antonell A; Lladó A; Sánchez-Valle R; Fortea J; Lleó A
Ann Clin Transl Neurol; 2019 Dec; 6(12):2518-2530. PubMed ID: 31789459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
